In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forward Pharma AS

www.forward-pharma.com

Latest From Forward Pharma AS

Deals Of The Year: Cast Your Vote For Top Alliance Of 2017

It's time for In Vivo's10th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners. (It's free.) First up, the top five picks for most significant strategic alliance of 2017.

Deals Financing

Biogen Makes Lifecycle Gambit In Next-Gen MS Drug Deal With Alkermes

ALKS 8700 could help Biogen extend its MS franchise beyond Tecfidera. The next-generation fumarate may have better GI tolerability and patent protection into 2033.

Life Cycle Management Deals

Biopharma Quarterly Deal-Making Statistics, Q1 2017

Biopharma financing decreased by 29% in the first quarter of 2017; conversely, M&As set a record, reaching $61.9 billion. The largest alliance of the quarter involved the microbiome.

BioPharmaceutical Deals

Biogen Staying "Laser-Focused" On Neuroscience

The company is under pressure from investors to add new pipeline assets, but stronger than expected initial sales of Spinraza helped to assuage near-term growth concerns.

Sales & Earnings Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Dermatology
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • Forward Pharma AS
  • Senior Management
  • Claus Bo Svendsen, MD, PhD, CEO
    Peter Moller Andersen, MD, COO
    Andrzej Jan Stano, PhD, EVP, Pharma Dev. & Production
  • Contact Info
  • Forward Pharma AS
    Phone: 33 44 42 42
    Ostergade 24A, 1
    Copenhagen K, 1100
    Denmark
UsernamePublicRestriction

Register